Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
Compare Balance Sheet Results of Biogen Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
65.26
3.00
62.26
2,075.33%
Share Warrants & Outstandings
Total Reserve
-9.03
55.85
-64.88
-116.17%
Shareholder's Funds
91.93
58.85
33.08
56.21%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0
0
0.00
0.00%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0.00
-0.93
0.93
100.00%
Other Long Term Liabilities
0.09
0.11
-0.02
-18.18%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
1.43
-1.43
-100.00%
Total Non-Current Liabilities
0.00
-0.93
0.93
100.00%
Current Liabilities
Trade Payables
0.00
0.04
-0.04
-100.00%
Other Current Liabilities
0.00
0.30
-0.30
-100.00%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
0.00
1.43
-1.43
-100.00%
Total Current Liabilities
0.18
4.12
-3.94
-95.63%
Total Liabilities
92.02
60.50
31.52
52.10%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.00
0.94
-0.94
-100.00%
Less: Accumulated Depreciation
0.00
0.51
-0.51
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.00
0.42
-0.42
-100.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0
0
0.00
0.00%
Long Term Loans & Advances
65.50
0.00
65.50
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.57
0.43
0.14
32.56%
Current Assets Loans & Advances
Current Investments
23.84
54.37
-30.53
-56.15%
Inventories
0.00
0.00
0.00
0.00%
Sundry Debtors
0.00
0.00
0.00
0.00%
Cash and Bank
2.02
4.33
-2.31
-53.35%
Other Current Assets
0
0
0.00
0.00%
Short Term Loans and Advances
0.00
0.30
-0.30
-100.00%
Total Current Assets
25.86
59.00
-33.14
-56.17%
Net Current Assets (Including Current Investments)
25.68
54.89
-29.21
-53.22%
Total Current Assets Excluding Current Investments
2.02
4.63
-2.61
-56.37%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
92.02
60.50
31.52
52.10%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
0.86
196.17
-195.31
-99.56%
Annual - Borrowings
No Borrowings in the last few periods
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -70.00% vs 25.00% in Mar 2024
Annual - Fixed Assets
No Fixed Assets in the last few periods
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.86 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 373.63% vs -39.20% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
